123 related articles for article (PubMed ID: 2151880)
1. The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
Schulz P; Wolf D; Arbusow V; Bojar H; Klobeck HG; Fittler F
Andrologia; 1990; 22 Suppl 1():56-66. PubMed ID: 2151880
[TBL] [Abstract][Full Text] [Related]
2. Androgens induce divergent proliferative responses in human breast cancer cell lines.
Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145.
Sigala S; Tognazzi N; Rizzetti MC; Faraoni I; Missale C; Bonmassar E; Spano P
Eur J Endocrinol; 2002 Sep; 147(3):407-15. PubMed ID: 12213679
[TBL] [Abstract][Full Text] [Related]
4. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
Olea N; Sakabe K; Soto AM; Sonnenschein C
Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
[TBL] [Abstract][Full Text] [Related]
5. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
[TBL] [Abstract][Full Text] [Related]
6. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
Berns EM; de Boer W; Mulder E
Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
[TBL] [Abstract][Full Text] [Related]
8. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.
Sica G; Dell'Acqua G; Iacopino F; Fattorossi A; Marchetti P; van der Kwast TH; Pavone-Macaluso M
Urol Res; 1994; 22(1):33-8. PubMed ID: 8073539
[TBL] [Abstract][Full Text] [Related]
10. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
Grant ES; Batchelor KW; Habib FK
Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells.
Hackenberg R; Hofmann J; Hölzel F; Schulz KD
J Cancer Res Clin Oncol; 1988; 114(6):593-601. PubMed ID: 2974456
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of prostate kallikrein-like genes by androgen.
Wolf DA; Schulz P; Fittler F
Mol Endocrinol; 1992 May; 6(5):753-62. PubMed ID: 1376410
[TBL] [Abstract][Full Text] [Related]
13. Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.
Wolf DA; Schulz P; Fittler F
Br J Cancer; 1991 Jul; 64(1):47-53. PubMed ID: 1713053
[TBL] [Abstract][Full Text] [Related]
14. Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro.
Bologna M; Muzi P; Biordi L; Festuccia C; Vicentini C
Urology; 1995 Feb; 45(2):282-90. PubMed ID: 7855976
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
Cops EJ; Bianco-Miotto T; Moore NL; Clarke CL; Birrell SN; Butler LM; Tilley WD
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):236-43. PubMed ID: 18515094
[TBL] [Abstract][Full Text] [Related]
16. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
Warriar N; Pagé N; Koutsilieris M; Govindan MV
Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
[TBL] [Abstract][Full Text] [Related]
18. Suppression of mutant androgen receptors by flutamide.
Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
[TBL] [Abstract][Full Text] [Related]
19. Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells.
Rossi R; Zatelli MC; Valentini A; Cavazzini P; Fallo F; del Senno L; degli Uberti EC
J Endocrinol; 1998 Dec; 159(3):373-80. PubMed ID: 9834454
[TBL] [Abstract][Full Text] [Related]
20. Regulation of growth hormone receptors in human prostate cancer cell lines.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
